Women Cancer Awareness Package

Women’s cancer awareness package is a group of packages clubbed together to detect cancer markers in women. It is important for women to know family history and symptoms, and go for regular check-ups and pelvic examinations to detect cancer at an early stage. This package measures the levels of specific tumor markers or antigens in the blood. The following tests are included in the women cancer awareness packages.

Women’s cancer awareness package is a group of packages clubbed together to detect cancer markers in women. This package measures the levels of specific tumor markers or antigens in the blood. The following tests are included in the women cancer awareness packages.

CA125
CA 125 is a protein that is present on the surface of the majority of ovarian cancer cells. Thus, women having ovarian cancer will show high levels of CA 125. This test is used to
Monitor the treatment and recurrence of ovarian cancer.
CA125 test is done to detect ovarian cancer, to monitor the treatment of ovarian cancer
It is also done to detect lump (mass) in the pelvic region.

CEA
Carcinoembryonic antigen (CEA) is a tumor marker protein that is normally present at very low levels in the blood in adults. However, in certain cases like cancer, the levels may get elevated. This test measures the amount of CEA in the blood to help evaluate individuals diagnosed with cancer. CEA is a tumor marker for colon cancer and a variety of other cancers like pancreas, breast, lung, ovarian, medullary thyroid, or other cancer. The carcinoembryonic antigen test is done to
To monitor cancer treatment (colon, pancreas, breast, lung, ovarian, medullary thyroid, or other cancer) including response to therapy and recurrence
As an indicator of the extent of cancer or size of tumor present (tumor burden)
To assist in cancer staging
As a follow-up to a positive screening test for cancer: to compare whether the level falls to normal (indicating that the cancer was all likely removed) after treatment for cancer

CA15.3
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is especially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease. Since CA 15.3 is measured in the blood, it is useful as a tumor marker to follow the course of cancer.CA 15.3 is found to be elevated in some women with early localized, breast cancer or those with a small tumor. However, it can also be elevated in some women with breast cancer that has spread (metastatic).